| Revenue growth | 83.86% YoY growth for FY26. |
|---|---|
| Margins | Gross margin expanded 714 bps to 60.28% in FY26. |
| Demand visibility | Strong on-ground visibility from 2,500+ store network. |
| Management confidence | High; confident in scaling to 5,000+ stores by FY29. |
Growth
FY26 consol revenue stood at ₹53,865 lakhs (up 83.86% YoY); EBITDA at ₹2,597 lakhs vs negative in FY25.
Outlook
Targeting 5,000+ Davaindia stores by FY29; planned addition of 500-700 stores in FY27.
Risks
Expansion moderation in Q2/Q3 to focus on profitability; MSME compliance reducing payable days.
Earnings Call filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,336.60
- Market cap
- ₹4,629 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -44.9×Sector 50.4×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 7.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Annual General Meeting
Zota Health Care responded to a proxy advisory firm's negative recommendations on upcoming AGM resolutions, defending proposed director remuneration and related party transactions with its subsidiary.
Zota Healthcare Management Change
Zota Health Care Limited announced the cessation of Mrs. Varshabahen Gaurang Mehta as an Independent Director effective September 09, 2026, upon the completion of her tenure.
Zota Healthcare Management Change
Zota Health Care Limited appointed Mr. Mahaveer Dhariwal as a Non-Executive Independent Director, effective September 3, 2026. The board approved this leadership appointment.
Zota Healthcare Annual General Meeting
Zota Health Care has fixed September 21, 2026, as the record date for its upcoming Annual General Meeting and final dividend payment.
Zota Healthcare Board Meeting Outcome
Zota Health Care Limited's board approved the Notice of the 26th AGM and set the record date for the final dividend. They also appointed a new Independent Director.
Zota Healthcare Earnings Call Transcript: Key Takeaways
Zota reported 67.6% YoY revenue growth in Q1 FY27, driven by Davaindia network expansion. Management expects EBITDA positivity to resume from Q2 and cash breakeven by Q1 FY28.